NanoVibronix Operating Margin from 2010 to 2025
| NAOV Stock | USD 4.35 0.10 2.35% |
Check NanoVibronix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NanoVibronix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 945, Interest Expense of 268.8 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 10.59, Dividend Yield of 0.0 or PTB Ratio of 5.25. NanoVibronix financial statements analysis is a perfect complement when working with NanoVibronix Valuation or Volatility modules.
NanoVibronix | Operating Margin |
Latest NanoVibronix's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of NanoVibronix over the last few years. It is NanoVibronix's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NanoVibronix's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (2.58) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
NanoVibronix Operating Margin Regression Statistics
| Arithmetic Mean | (6.77) | |
| Geometric Mean | 5.46 | |
| Coefficient Of Variation | (56.34) | |
| Mean Deviation | 2.99 | |
| Median | (6.66) | |
| Standard Deviation | 3.81 | |
| Sample Variance | 14.53 | |
| Range | 12.1814 | |
| R-Value | 0.40 | |
| Mean Square Error | 13.12 | |
| R-Squared | 0.16 | |
| Significance | 0.13 | |
| Slope | 0.32 | |
| Total Sum of Squares | 217.98 |
NanoVibronix Operating Margin History
About NanoVibronix Financial Statements
NanoVibronix investors use historical fundamental indicators, such as NanoVibronix's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NanoVibronix. Please read more on our technical analysis and fundamental analysis pages.
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. Nanovibronix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.